Navigating Medical Device Safety: Current Status, Challenges, and Future Regulatory Directions.

Medical devices are indispensable in modern healthcare. They enable the prevention, diagnosis, and treatment of diseases while enhancing patient outcomes. However, the increasing complexity of these devices, particularly those incorporating advanced technologies such as artificial intelligence (AI) introduces new challenges to their safe use. The vulnerabilities of medical devices can lead to adverse events ranging from minor complications to severe injuries or fatalities, and there is an increasing health risk to those devices that are interconnected to electronic health management systems and internet protocols. Despite efforts by regulatory authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Health Canada, disparities in reporting systems and monitoring practices persist globally, hindering effective safety oversight. This paper explores the current landscape of medical device safety, focusing on regulatory frameworks, reporting systems, and the challenges posed by fragmented data collection and underreporting. It highlights the critical role of postmarket surveillance (PMS) in identifying risks and ensuring device performance in real-world settings. The integration of emerging technologies, such as AI for predictive safety and blockchain for traceability, offers promising solutions to enhance monitoring and mitigate risks early in the device lifecycle. In addition, the paper examines harmonization efforts led by organizations such as The International Medical Device Regulators Forum (IMDRF), the International Society of Pharmacovigilance (ISoP) and the World Health Organazition (WHO), which aim to standardize reporting practices and improve global collaboration. Key recommendations include leveraging real-world data, enhancing cybersecurity measures, and fostering international cooperation to streamline regulatory processes. By addressing these challenges and embracing innovation, stakeholders can ensure that medical devices continue to advance healthcare while maintaining the highest safety standards. Such collective efforts are essential for safeguarding patient trust and improving global health outcomes.